HFS
MRNA icon

Hantz Financial Services’s Moderna MRNA Stock Holding History

Hantz Financial Services’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$335K Sell
4,789
-283
-6% -$14.6K ﹤0.01% 895
2026
Q1 		$258K Buy
5,072
+1,669
+49% +$77.9K ﹤0.01% 902
2025
Q4 		$100K Buy
3,403
+691
+25% +$18.8K ﹤0.01% 1145
2025
Q3 		$70K Buy
2,712
+1,985
+273% +$55.4K ﹤0.01% 1108
2025
Q2 		$20K Buy
727
+630
+649% +$16.6K ﹤0.01% 1276
2025
Q1 		$3K Sell
97
-13
-12% -$461 ﹤0.01% 1301
2024
Q4 		$5K Sell
110
-45
-29% -$2.15K ﹤0.01% 893
2024
Q3 		$10K Buy
155
+2
+1% +$184 ﹤0.01% 791
2024
Q2 		$18K Sell
153
-118
-44% -$14.9K ﹤0.01% 738
2024
Q1 		$29K Sell
271
-170
-39% -$17.1K ﹤0.01% 711
2023
Q4 		$44K Buy
441
+2
+0.5% +$168 ﹤0.01% 662
2023
Q3 		$45K Buy
439
+19
+5% +$2.12K ﹤0.01% 641
2023
Q2 		$51K Hold
420
– – ﹤0.01% 623
2023
Q1 		$65K Buy
420
+1
+0.2% +$165 ﹤0.01% 599
2022
Q4 		$75K Buy
419
+127
+43% +$20.8K ﹤0.01% 587
2022
Q3 		$35K Hold
292
– – ﹤0.01% 621
2022
Q2 		$42K Hold
292
– – ﹤0.01% 603
2022
Q1 		$50K Buy
+292
New +$49.2K ﹤0.01% 612
2021
Q1 		– Sell
-801
Closed -$84K – 721
2020
Q4 		$84K Buy
801
+733
+1,078% +$74.2K ﹤0.01% 472
2020
Q3 		$5K Sell
68
-35
-34% -$2.44K ﹤0.01% 519
2020
Q2 		$7K Buy
+103
New +$5.64K ﹤0.01% 492

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Hantz Financial Services's MRNA Position: Q2 2026 in Review

Hantz Financial Services reduced its Moderna (MRNA) stake by 5.6% in Q2 2026, selling an estimated $14.6K and leaving 4,789 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #895.

Hantz Financial Services first reported a position in MRNA in Q2 2020 and has held it in 21 quarters since. 784 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Hantz Financial Services held 4,789 shares of Moderna worth $335K as of Q2 2026.
  • Hantz Financial Services sold 283 Moderna shares in Q2 2026, an estimated $14.6K.
  • Moderna made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #895 holding.
  • Hantz Financial Services first reported a position in Moderna in Q2 2020 and has held it in 21 quarters since.
  • 784 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.